Abrdn Healthcare Investors (HQH)
NYSE: HQH · Real-Time Price · USD
21.84
-0.17 (-0.77%)
Jul 31, 2026, 4:00 PM EDT - Market closed
HQH Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Equivalents | - | 0 | 0 | 0 | 0 | 0 |
Cash & Short-Term Investments | - | 0 | 0 | 0 | 0 | 0 |
Cash Growth | - | 5.36% | -73.83% | -72.98% | -15.29% | - |
Accounts Receivable | 1.26 | 2.54 | 0.5 | 6.85 | 2.87 | 4.05 |
Other Receivables | 0.01 | 0.01 | 0.01 | - | - | - |
Receivables | 1.27 | 2.55 | 0.51 | 6.85 | 2.87 | 4.05 |
Prepaid Expenses | 0.11 | 0.08 | 0.09 | 0.05 | 0.05 | 0.05 |
Other Current Assets | - | - | - | 32.74 | 39.79 | 8.3 |
Total Current Assets | 1.38 | 2.63 | 0.6 | 39.64 | 42.71 | 12.4 |
Long-Term Investments | 1,118 | 1,073 | 1,039 | 824.65 | 804.79 | 1,072 |
Other Long-Term Assets | 20.59 | 21.84 | 21.56 | 68.2 | 78.78 | 88.44 |
Total Assets | 1,140 | 1,097 | 1,061 | 932.49 | 926.28 | 1,173 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Accounts Payable | 0.04 | 1.21 | - | - | - | - |
Accrued Expenses | 1.31 | 1.12 | 1.13 | 1.15 | 1.22 | 1.29 |
Short-Term Debt | - | - | - | - | 8.5 | 11.33 |
Other Current Liabilities | 0.01 | 1.09 | 0.26 | - | - | 3.01 |
Total Current Liabilities | 1.35 | 3.43 | 1.4 | 1.15 | 9.71 | 15.63 |
Other Long-Term Liabilities | 1.75 | - | - | - | - | - |
Total Liabilities | 3.1 | 3.43 | 1.4 | 1.15 | 9.71 | 15.63 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Common Stock | 0.57 | 0.56 | 0.52 | 0.49 | 0.47 | 0.45 |
Additional Paid-In Capital | 1,023 | 991.69 | 941.13 | 924.88 | 891.27 | 853.35 |
Retained Earnings | 113.81 | 101.59 | 117.95 | 5.97 | 24.82 | 303.1 |
Shareholders' Equity | 1,137 | 1,094 | 1,060 | 931.34 | 916.56 | 1,157 |
Total Liabilities & Equity | 1,140 | 1,097 | 1,061 | 932.49 | 926.28 | 1,173 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Total Debt | - | - | - | - | 8.5 | 11.33 |
Net Cash (Debt) | - | 0 | 0 | 0 | -8.49 | -11.33 |
Net Cash Growth | - | 5.36% | -73.83% | - | - | - |
Net Cash Per Share | - | - | - | - | -0.18 | -0.25 |
Filing Date Shares Outstanding | 57.19 | 55.51 | 52.13 | 49.44 | 47.34 | 45.43 |
Total Common Shares Outstanding | 57.19 | 55.51 | 52.13 | 49.44 | 47.34 | 45.43 |
Working Capital | 0.03 | -0.8 | -0.79 | 38.49 | 33 | -3.23 |
Book Value Per Share | 19.88 | 19.70 | 20.33 | 18.84 | 19.36 | 25.47 |
Tangible Book Value | 1,137 | 1,094 | 1,060 | 931.34 | 916.56 | 1,157 |
Tangible Book Value Per Share | 19.88 | 19.70 | 20.33 | 18.84 | 19.36 | 25.47 |